ADMA Biologics, Inc.
ADMA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $197,673 | -$28,239 | -$65,904 | -$71,648 |
| Dep. & Amort. | $8,045 | $8,332 | $7,113 | $5,496 |
| Deferred Tax | -$84,280 | $0 | $0 | $221 |
| Stock-Based Comp. | $13,616 | $6,187 | $5,215 | $3,488 |
| Change in WC | -$18,539 | -$10,123 | -$18,285 | -$51,680 |
| Other Non-Cash | $2,157 | $32,643 | $12,353 | $1,755 |
| Operating Cash Flow | $118,672 | $8,800 | -$59,508 | -$112,369 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$8,226 | -$4,771 | -$13,911 | -$13,511 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$349 | -$210 | $0 | $0 |
| Investing Cash Flow | -$8,575 | -$4,981 | -$13,911 | -$13,511 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$60,000 | -$23,601 | $51,714 | -$34 |
| Stock Issued | $7,494 | $0 | $64,645 | $121,144 |
| Stock Repurch. | $0 | -$1,415 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5,796 | -$13,973 | -$7,507 | -$62 |
| Financing Cash Flow | -$58,302 | -$38,989 | $108,852 | $121,048 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $51,795 | -$35,170 | $35,432 | -$4,832 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $51,352 | $86,522 | $51,089 | $55,921 |
| End Cash | $103,147 | $51,352 | $86,522 | $51,089 |
| Free Cash Flow | $110,097 | $3,819 | -$73,419 | -$125,880 |